Product Information
KETOPROFEN ER 200 MG CAPSULE is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $6.4618 per EA under NDC 00378820001. Its NADAC has been published 305 times since Nov 28, 2013.
Strength
200 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378820001
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
3/18/2026
Active Ingredients
KETOPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA075679On Market Since
9/4/2003
Pharmacological Classes
Price Statistics
The NADAC for KETOPROFEN ER 200 MG CAPSULE has been published 305 times since Nov 28, 2013, and over the history we have for it it has risen 6.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.4618 per EA |
|---|---|
| All-time high | $8.4403 (May 11, 2016) |
| All-time low | $5.6405 (Dec 17, 2014) |
| 52-week high | $6.4618 |
| 52-week low | $5.6514 |
| Median price | $6.6186 |
| Average price | $6.9566 |
| Largest weekly change | +24.7% (Dec 23, 2015) |
| Weeks tracked | 305 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ketoprofen market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of KETOPROFEN ER 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for KETOPROFEN ER 200 MG CAPSULE, manufactured by Mylan Pharmaceuticals Inc., is $6.4618 per EA (NDC 00378820001), effective Jun 24, 2026.
How has the price of KETOPROFEN ER 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for KETOPROFEN ER 200 MG CAPSULE has risen 6.8%. It has been tracked across 305 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for KETOPROFEN ER 200 MG CAPSULE?
Since Nov 28, 2013, the NADAC for KETOPROFEN ER 200 MG CAPSULE has ranged from a low of $5.6405 (Dec 17, 2014) to a high of $8.4403 (May 11, 2016), with a median of $6.6186 per EA.
Are there cheaper alternatives to KETOPROFEN ER 200 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of KETOPROFEN ER 200 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures KETOPROFEN ER 200 MG CAPSULE?
KETOPROFEN ER 200 MG CAPSULE (NDC 00378820001) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification